Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Sonoma Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Mar 2028 | $26.95M | $26.95M - $26.95M | -$8.43M | $0.07 | 1 |
| Mar 2027 | $23.91M | $23.91M - $23.91M | -$7.48M | -$0.56 | 1 |
| Mar 2026 | $20.66M | $20.66M - $20.66M | -$6.46M | -$1.61 | 1 |
| Mar 2025 | $15.47M | $15.47M - $15.47M | -$4.84M | -$0.67 | 1 |
| Mar 2024 | $12.70M | $12.70M - $12.70M | -$3.97M | -$7.529 | 1 |
| Mar 2023 | $13.56M | $13.17M - $13.94M | -$4.24M | -$24.80 | 1 |
| Mar 2022 | $37.14M | $36.09M - $38.18M | -$11.62M | -$61.20 | 1 |
| Mar 2021 | $29.86M | $29.02M - $30.70M | -$9.34M | -$171.00 | 1 |
| Mar 2020 | $19.20M | $18.66M - $19.74M | -$6.01M | -$76.40 | 1 |
| Mar 2019 | $19.00M | $18.46M - $19.54M | -$5.95M | -$255.40 | 1 |
| Mar 2018 | $17.40M | $16.91M - $17.89M | -$5.45M | -$515.70 | 1 |
| Mar 2017 | $14.57M | $14.16M - $14.98M | -$4.56M | $376.20 | 1 |